At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Vibrant capsule +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized, Multi-center, Double-Blinded, Clinical Study to Assess the Efficacy and Safety of Vibrant Capsule vs. Placebo, for the Treatment of Chronic Idiopathic Constipation
In Brief
A clinical study evaluating Vibrant capsule and Placebo capsule for Constipation Chronic Idiopathic. Completed, enrolled 100 participants across 2 sites.
Detailed Summary
The objectives are to assess the efficacy and safety of Vibrant capsule administered twice a week
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConstipation Chronic Idiopathic
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJul 2021
First PostedSep 2021
Primary CompletionDec 2022
TodayJul 2026
First PostedSep 5, 2021
Enrollment StartJul 5, 2021
Primary CompletionDec 15, 2022
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 4.8 years ago
Interventions
Vibrant capsuledevice
Vibrant capsule - Administered twice a week (Monday and Thursday).
Placebo capsuledevice
Placebo Capsule administered twice a week (Monday and Thursday)